FR2503562B1 - Conditionnement pharmaceutique pour le traitement des symptomes de menopause - Google Patents
Conditionnement pharmaceutique pour le traitement des symptomes de menopauseInfo
- Publication number
- FR2503562B1 FR2503562B1 FR8206143A FR8206143A FR2503562B1 FR 2503562 B1 FR2503562 B1 FR 2503562B1 FR 8206143 A FR8206143 A FR 8206143A FR 8206143 A FR8206143 A FR 8206143A FR 2503562 B1 FR2503562 B1 FR 2503562B1
- Authority
- FR
- France
- Prior art keywords
- treatment
- menopause symptoms
- conditioning
- pharmaceutical
- pharmaceutical conditioning
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/252,518 US4425339A (en) | 1981-04-09 | 1981-04-09 | Treatment of menopausal symptoms |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2503562A1 FR2503562A1 (fr) | 1982-10-15 |
FR2503562B1 true FR2503562B1 (fr) | 1985-07-12 |
Family
ID=22956353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8206143A Expired FR2503562B1 (fr) | 1981-04-09 | 1982-04-08 | Conditionnement pharmaceutique pour le traitement des symptomes de menopause |
Country Status (6)
Country | Link |
---|---|
US (1) | US4425339A (fr) |
BE (1) | BE892801A (fr) |
DE (1) | DE3213248A1 (fr) |
FR (1) | FR2503562B1 (fr) |
GB (1) | GB2096462B (fr) |
NL (1) | NL8201512A (fr) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4390531A (en) * | 1981-08-10 | 1983-06-28 | Syntex Pharmaceuticals International Ltd. | Method of contraception using peak progestogen dosage |
US4961931A (en) * | 1982-07-29 | 1990-10-09 | Alza Corporation | Method for the management of hyperplasia |
AU582540B2 (en) * | 1983-08-05 | 1989-04-06 | Pre Jay Holdings Ltd. | A method of hormonal treatment of perimenopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor |
US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
US4962098A (en) * | 1987-06-15 | 1990-10-09 | Warner-Lambert Company | Graduated estrogen contraceptive |
US5010070A (en) * | 1987-06-15 | 1991-04-23 | Warner-Lambert Company | Graduated estrogen contraceptive |
US4816257A (en) * | 1985-09-20 | 1989-03-28 | Research & Education Institute, Harbor-Ucla Medical Center Inc. | Method for producing an in vivo environment suitable for human embryo transfer |
US5208225A (en) * | 1986-02-27 | 1993-05-04 | Warner-Lambert Company | Compositions containing fixed combinations |
SE8602666D0 (sv) * | 1986-06-16 | 1986-06-16 | Leo Ab | Intravaginal devices |
DK174724B1 (da) * | 1986-07-15 | 2003-10-06 | Wyeth Corp | Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet |
US4855305A (en) * | 1987-03-23 | 1989-08-08 | Applied Medical Research | Compositions and methods of effecting contraception utilizing melatonin |
US4900734A (en) * | 1987-08-27 | 1990-02-13 | Maxson Wayne S | Novel pharmaceutical composition containing estradiol and progesterone for oral administration |
US5276022A (en) * | 1987-09-24 | 1994-01-04 | Jencap Research Ltd. | Hormone preparation and method |
US5108995A (en) * | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
DK174071B1 (da) * | 1987-09-24 | 2002-05-21 | Jencap Res Ltd | Kontraceptivt præparat i form af en pakning omfattende enhedsdoser |
HUT52382A (en) * | 1988-03-14 | 1990-07-28 | Sandoz Ag | Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case |
US5043331A (en) * | 1989-06-15 | 1991-08-27 | Orion-Yhtyma Oy | Treatment of postmenopausal disorders |
US5883087A (en) * | 1991-01-07 | 1999-03-16 | Pherin Corporation | Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
US5783571A (en) * | 1991-01-07 | 1998-07-21 | Pherin Corporation | Method of altering hypothalamic function by nasal administration of estrene steroids |
US5925774A (en) | 1991-01-07 | 1999-07-20 | Pherin Corporation | Estrenes for inducing hypothalamic effects |
US5969168A (en) * | 1991-01-07 | 1999-10-19 | Pherin Corporation | Androstanes for inducing hypothalamic effects |
ATE275957T1 (de) * | 1993-01-19 | 2004-10-15 | Endorech Inc | Therapeutische verwendungen und verabreichungsysteme von dehydroepiandrosteron |
US5776923A (en) * | 1993-01-19 | 1998-07-07 | Endorecherche, Inc. | Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone |
BR9307866A (pt) * | 1993-06-15 | 1996-07-30 | Pherin Corp | Esteróides estreno como iniciadores neuroquímicos de mudança em funçao hipotalamica humana e composiçoes farmaceuticas relacionadas e processos |
US5591753A (en) * | 1994-01-28 | 1997-01-07 | Eli Lilly And Company | Combination treatment for osteoporosis |
DE4429374C1 (de) * | 1994-08-12 | 1996-02-01 | Jenapharm Gmbh | Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente |
US5759577A (en) * | 1995-01-17 | 1998-06-02 | American Home Products Corporation | Controlled release of steroids from sugar coatings |
US5547948A (en) * | 1995-01-17 | 1996-08-20 | American Home Products Corporation | Controlled release of steroids from sugar coatings |
US5861431A (en) * | 1995-06-07 | 1999-01-19 | Iotek, Inc. | Incontinence treatment |
US20010031244A1 (en) * | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
US6432932B1 (en) | 1997-07-22 | 2002-08-13 | Merck & Co., Inc. | Method for inhibiting bone resorption |
US5994329A (en) | 1997-07-22 | 1999-11-30 | Merck & Co., Inc. | Method for inhibiting bone resorption |
US6703367B1 (en) | 1999-04-27 | 2004-03-09 | Praecis Pharmaceuticals Inc. | Methods for treating hot flashes and gynaecomastia |
AU2580001A (en) | 1999-12-20 | 2001-07-03 | Merck & Co., Inc. | Blister package for pharmaceutical treatment card |
US6855703B1 (en) | 2000-03-10 | 2005-02-15 | Endeavor Pharmaceuticals | Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds |
US6660726B2 (en) | 2000-03-10 | 2003-12-09 | Endeavor Pharmaceuticals | Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same |
US7459445B2 (en) * | 2000-03-10 | 2008-12-02 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds and topical pharmaceutical formulations of the same |
US7989436B2 (en) * | 2003-07-23 | 2011-08-02 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds and pharmaceutical formulations comprising the same |
EP1390038A2 (fr) * | 2001-05-16 | 2004-02-25 | Endeavor Pharmaceuticals | Traitement d'etats lies a un deficit en hormones par administration de progestatifs |
CA2480814A1 (fr) * | 2002-04-05 | 2003-10-23 | Merck & Co., Inc. | Procede d'inhibition de resorption osseuse a l'aide d'une formulation a base d'alendronate et de vitamine d |
US6992075B2 (en) * | 2003-04-04 | 2006-01-31 | Barr Laboratories, Inc. | C(14) estrogenic compounds |
JP2006522833A (ja) * | 2003-04-11 | 2006-10-05 | バー・ラボラトリーズ,インコーポレイテッド | エストロゲンおよびプロゲスチンの投与法 |
US20050261250A1 (en) * | 2004-05-19 | 2005-11-24 | Merck & Co., Inc., | Compositions and methods for inhibiting bone resorption |
US7623924B2 (en) * | 2004-08-31 | 2009-11-24 | Leptos Biomedical, Inc. | Devices and methods for gynecologic hormone modulation in mammals |
CA2601773A1 (fr) * | 2005-02-03 | 2006-08-10 | Duramed Pharmaceuticals, Inc. | Compositions d'oestrogenes non conjugues et procedes destines a leur utilisation |
UY33103A (es) | 2009-12-15 | 2011-07-29 | Techsphere S A De C V | Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3568828A (en) | 1967-03-01 | 1971-03-09 | Squibb & Sons Inc | Modified sequential oral contraceptive |
US3409721A (en) * | 1967-09-15 | 1968-11-05 | Neomed Lab Inc | Oral dosage system effective to control the reproduction cycle |
US3608075A (en) | 1969-07-28 | 1971-09-21 | American Home Prod | Compositions and methods of treating the menopausal syndrome |
US3733407A (en) * | 1971-08-25 | 1973-05-15 | Syntex Corp | Menopause treatment |
US3932635A (en) | 1972-04-24 | 1976-01-13 | Syntex Corporation | Novel cyclic progestogen-interrupted estrogen oral contraceptive regimens |
DE2365103C3 (de) | 1973-12-21 | 1980-08-28 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | V erwendung von Hormonen zur Kontrazeption |
US4145416A (en) | 1976-06-23 | 1979-03-20 | Schering, A.G. | Novel agents and novel methods for treatment of climacteric disturbances |
-
1981
- 1981-04-09 US US06/252,518 patent/US4425339A/en not_active Expired - Fee Related
-
1982
- 1982-04-08 GB GB8210501A patent/GB2096462B/en not_active Expired
- 1982-04-08 BE BE0/207787A patent/BE892801A/fr not_active IP Right Cessation
- 1982-04-08 DE DE19823213248 patent/DE3213248A1/de not_active Withdrawn
- 1982-04-08 NL NL8201512A patent/NL8201512A/nl not_active Application Discontinuation
- 1982-04-08 FR FR8206143A patent/FR2503562B1/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE3213248A1 (de) | 1982-11-04 |
GB2096462A (en) | 1982-10-20 |
FR2503562A1 (fr) | 1982-10-15 |
GB2096462B (en) | 1984-06-27 |
BE892801A (fr) | 1982-10-08 |
NL8201512A (nl) | 1982-11-01 |
US4425339A (en) | 1984-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2503562B1 (fr) | Conditionnement pharmaceutique pour le traitement des symptomes de menopause | |
MA18939A1 (fr) | Procede de preparation d'un agent pour le traitement de theilerioses | |
FR2578421B1 (fr) | Compositions pharmaceutiques utiles pour le traitement des troubles de la memoire | |
BE890648A (fr) | Compositions pour le traitement de l'acne | |
BE854416A (fr) | Compositions pharmaceutiques pour le traitement des symptomes de la menopause et leur procede d'utilisation | |
FR2497510B1 (fr) | Composition pharmaceutique contenant de la g-butyrobetaine pour le traitement des syndromes provoques par une carence en l-carnitine | |
FR2499408B1 (fr) | Composition pharmaceutique pour le traitement de l'osteopathie, a base d'acide 6-amino-1-hydroxyhexane-1,1-diphosphonique | |
BE878731A (fr) | Installation pour le traitement des liquides impurs | |
FR2536995B1 (fr) | Composition pour le traitement de l'arthrite | |
BE894228A (fr) | Composition pharmaceutique pour le traitement de l'atherosclerose | |
MA22278A1 (fr) | Procede pour le traitement de troubles respiratoires | |
RO88351A3 (fr) | Composition pour le traitement des affections gastroduodenales | |
FR2573088B1 (fr) | Procede de traitement des vinasses | |
FR2562798B1 (fr) | Agent pharmaceutique pour le traitement du psoriasis | |
RO79428A2 (fr) | Composition medicamenteuse pour le traitement des dermatoses | |
FR2296415A1 (fr) | Preparations pharmaceutiques pour le traitement des troubles de la circulation | |
BE842389A (fr) | Composition pharmaceutique pour le traitement de l'hyperuricemie | |
OA08609A (fr) | Composition pharmaceutique pour le traitement des infections bactériennes. | |
BE856458A (fr) | Preparation pharmaceutique pour le traitement de l'osteoporose et procede pour le fabriquer | |
FR2517203B1 (fr) | Composition pour le traitement de l'acne | |
RO86650A2 (fr) | Prepare pharmaceutique pour le traitement des dermatoses | |
BE864979A (fr) | Compositions pour le traitement des etats asthmatiques | |
FR2536381B1 (fr) | Procede de traitement d'effluents liquides pollues | |
RO82400A2 (fr) | Onguent pour le traitement des vulvites distrophiques | |
RO84198A (fr) | Procede pour le traitement des eau0 residuaires de l'industrie e0tractive miniere |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |